These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21475329)

  • 1. Is chemotherapy associated with cognitive impairment?
    Zachariae R; Mehlsen MY
    Nat Rev Urol; 2011 Apr; 8(4):182-3. PubMed ID: 21475329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-related cognitive impairment or « chemobrain »: concept and state of art.
    Bompaire F; Durand T; Léger-Hardy I; Psimaras D; Ricard D
    Geriatr Psychol Neuropsychiatr Vieil; 2017 Mar; 15(1):89-98. PubMed ID: 28266346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.
    Boykoff N; Moieni M; Subramanian SK
    J Cancer Surviv; 2009 Dec; 3(4):223-32. PubMed ID: 19760150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An overview of the research of cancer-related cognitive impairment].
    Ferencz V; S Nagy Z; Tóth M
    Orv Hetil; 2019 Sep; 160(38):1495-1502. PubMed ID: 31537098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term cognitive function following chemotherapy in patients with testicular cancer.
    Pedersen AD; Rossen P; Mehlsen MY; Pedersen CG; Zachariae R; von der Maase H
    J Int Neuropsychol Soc; 2009 Mar; 15(2):296-301. PubMed ID: 19203434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
    Ongnok B; Chattipakorn N; Chattipakorn SC
    Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognitive deficits with chemotherapy in women with breast cancer: a bibliographic revisión].
    Arce B; Grañana N
    Rev Fac Cien Med Univ Nac Cordoba; 2023 Jun; 80(2):126-133. PubMed ID: 37402295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
    Reid-Arndt SA
    Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for breast cancer and cognitive impairment.
    Marín AP; Sánchez AR; Arranz EE; Auñón PZ; Barón MG
    South Med J; 2009 Sep; 102(9):929-34. PubMed ID: 19668023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy, neurotoxicity, and cognitive changes in breast cancer.
    Dutta V
    J Cancer Res Ther; 2011; 7(3):264-9. PubMed ID: 22044805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairment in men with testicular cancer prior to adjuvant therapy.
    Wefel JS; Vidrine DJ; Veramonti TL; Meyers CA; Marani SK; Hoekstra HJ; Hoekstra-Weebers JE; Shahani L; Gritz ER
    Cancer; 2011 Jan; 117(1):190-6. PubMed ID: 20737560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A meta-analysis of the sensitivity of various neuropsychological tests used to detect chemotherapy-induced cognitive impairment in patients with breast cancer.
    Jansen CE; Miaskowski CA; Dodd MJ; Dowling GA
    Oncol Nurs Forum; 2007 Sep; 34(5):997-1005. PubMed ID: 17878128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?
    Player L; Mackenzie L; Willis K; Loh SY
    Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of cognitive impairment following adult cancer chemotherapy.
    Lindner OC; Phillips B; McCabe MG; Mayes A; Wearden A; Varese F; Talmi D
    Neuropsychology; 2014 Sep; 28(5):726-40. PubMed ID: 24635712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy.
    Stouten-Kemperman MM; de Ruiter MB; Caan MW; Boogerd W; Kerst MJ; Reneman L; Schagen SB
    Hum Brain Mapp; 2015 Nov; 36(11):4638-47. PubMed ID: 26304182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress.
    Skaali T; Fosså SD; Andersson S; Cvancarova M; Langberg CW; Lehne G; Dahl AA
    J Psychosom Res; 2011 May; 70(5):403-10. PubMed ID: 21511070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
    Walker CH; Drew BA; Antoon JW; Kalueff AV; Beckman BS
    Cancer Invest; 2012 Feb; 30(2):135-48. PubMed ID: 22250588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
    Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
    Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study.
    Mitchell T; Turton P
    Eur J Cancer Care (Engl); 2011 Jul; 20(4):539-48. PubMed ID: 21443746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.